Slide thumbnail

ITOC Education Workshop on Cancer Immunotherapy

18 – 19
MAR 2017

“State of the art” & ongoing developments in cancer immunotherapy will take place in Prague, Czech Republic from March 18 – 19, 2017. Please view the preliminary program HERE. The ITOC-Education Congress Office offers 15 free registrations for the ITOC Education Workshop to CECOG members (15 free registrations on a first come, first served basis – further registrations certainly also welcome, but the respective registration fees will apply).

learn more
Slide thumbnail

EFR – Jubilee Congress

20 – 22
APRIL 2017

The European Federation for Colorectal Cancer is inviting you to the 10th EFR Congress to be held from April 20th–22nd, 2017 at the Medical University of Vienna.

Please find the program details HERE.

Programme PDF
Slide thumbnail

Immune Checkpoint Inhibitor Treatment

12 - 13
MAY 2017

Sponsored with a grant of Bristol- Myers-Squibb

Location in Vienna (Hotel de France)
Participation is only possible with a personal invitation.
This very successful event takes place for the 6th time.

Slide thumbnail

CECOG Targeted Drug Fellowship Programm

Fellowship
Programm

We welcome our current fellow Mr. Nikola Milašević, MD. He participates in the program from 16th of january to 24th of february at the Department of Medicine I, Clinical Division of Oncology. This program enables young oncologists from mainly Central and Eastern Europe to gain experience with cancer treatment using biological agents.

learn more
  • CECOG: Our Mission

    We strive to interact with the highest esteem for each other and with the overriding aim to improve the well-being and fate of patients.

Our Services

About CEGOG

frontpagevideo2

With the aim to coordinate clinical trials in oncology according to the standards of Good clinical Practice in the area of Central- and Southeastern Europe, the foundation of CECOG was laid in 1999.

CECOG’s range of activity is not only limited to the conduct of clinical trials but also concentrates on education and the definition of quality standards in regard to the care of patients with malignant diseases.

ZielinskiSignature02

 

Univ. Prof. Dr. Christoph Zielinski

CECOG Facts & Figures